BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Corrective action for the cobas HbA1c Test on the cobas b101 System, Roche

Product group In-vitro diagnostics - equipment / products for clinical chemistry
Reference 05375/13

Corrective action from Roche for the cobas HbA1c Test on the cobas b101 System due to increased imprecision and bias of results. Customers were informed about the problem.

According the information by the manufacturer German customers are not affected.

Corrective action for the cobas HbA1c Test on the cobas b101 System, Roche , Download_VeroeffentlichtAm_EN PDF, 99KB, File does not meet accessibility standards